ACRP talked to Chris Komelasky, CEO & Founder of Site Bridge Research, about what steps need to be taken to broaden clinical research into underserved and minority populations.
“Change is constant in clinical research,” says an expert who advocates for an agile approach to addressing underperforming areas in team operations.
Cancer patients ineligible for trials receive immune checkpoint inhibitors at greater rates than trial eligible ones despite no survival benefit.
A new coalition of health organizations hopes to improve patient care using clinical research evidence in real time.
PAID MESSAGE Decentralized clinical trials (DCTs) are becoming one of the most dynamic ways to conduct clinical research. The ability for research sites to deploy remote trials elevates opportunities easily […]